IRIS
FERRAU', Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.988
EU - Europa 1.688
AS - Asia 548
AF - Africa 2
OC - Oceania 1
SA - Sud America 1
Totale 4.228
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.986
IE - Irlanda 593
SE - Svezia 487
CN - Cina 429
IT - Italia 207
PL - Polonia 135
GB - Regno Unito 82
SG - Singapore 64
DE - Germania 44
IN - India 40
FI - Finlandia 34
UA - Ucraina 28
FR - Francia 25
BE - Belgio 22
VN - Vietnam 14
CZ - Repubblica Ceca 13
AT - Austria 8
RU - Federazione Russa 5
MX - Messico 2
NG - Nigeria 2
AL - Albania 1
AU - Australia 1
CL - Cile 1
GR - Grecia 1
HR - Croazia 1
MY - Malesia 1
NL - Olanda 1
NO - Norvegia 1
Totale 4.228
Salva come PNG Salva come JPEG
Città #
Dublin 592
Chandler 507
Nyköping 304
Beijing 180
Ashburn 142
Warsaw 134
Jacksonville 123
Princeton 104
Medford 96
Messina 80
Dearborn 77
Ann Arbor 76
Des Moines 73
Cambridge 65
Lancaster 54
Singapore 43
New York 40
Shenyang 39
Jinan 34
Boardman 29
Hyderabad 26
Wilmington 26
Nanjing 22
Brussels 21
Tianjin 21
Los Angeles 20
Seattle 18
Guangzhou 17
San Mateo 17
Dong Ket 14
Houston 14
Pune 14
Zhengzhou 14
Bremen 12
Hangzhou 12
Nanchang 12
Ningbo 12
Catania 10
Haikou 10
Taizhou 10
Woodbridge 10
Brno 8
Hebei 8
Vienna 8
Fairfield 7
Milan 7
Norwalk 7
Fort Worth 6
Fuzhou 6
Helsinki 5
Jiaxing 5
Turin 5
Changsha 4
Lanzhou 4
London 4
Munich 4
Rome 4
Vittoria 4
Clearwater 3
Genova 3
Lappeenranta 3
Naples 3
Olomouc 3
Oxford 3
Ragusa 3
Augusta 2
Brooklyn 2
Carrara 2
Caserta 2
Cisano Bergamasco 2
Cividale del Friuli 2
Dachau 2
Empoli 2
Floridia 2
Hongtong 2
Lagos 2
Livorno 2
Padova 2
Palermo 2
Pontedera 2
Redwood City 2
Reggio Calabria 2
San Mauro Marchesato 2
Tuxtla Gutiérrez 2
Baotou 1
Bergamo 1
Castelfranco Veneto 1
Ceska 1
Cleveland 1
Corigliano Calabro 1
Dorking 1
Drogheda 1
Glasgow 1
Kemerovo 1
Kuala Lumpur 1
Las Vegas 1
Mainz 1
Mascalucia 1
Milazzo 1
Monserrato 1
Totale 3.295
Salva come PNG Salva come JPEG
Nome #
Clinical management of critically ill patients with Cushing's disease due to ACTH-secreting pituitary macroadenomas: effectiveness of presurgical treatment with pasireotide 101
Diabetes secondary to acromegaly: Physiopathology, clinical features and effects of treatment 97
Acromegaly is more severe in patients with AHR or AIP gene variants living in highly polluted areas 91
Aggressive pituitary adenomas: the dark side of the moon 86
Cyberknife stereotactic treatment of pituitary adenomas: A single center experience using different irradiation schemes and modalities 82
Aggiornamento sulla chirurgia ipofisaria per via endoscopica: indicazioni, vantaggi e limiti 76
GSTP1 gene methylation and AHR rs2066853 variant predict resistance to first generation somatostatin analogs in patients with acromegaly 76
PRIMARY EMPTY SELLA IS ASSOCIATED WITH INCREASED CARDIOVASCULAR RISK, REGARDLESS THE OCCURRENCE OF PITUITARY DYSFUNCTION 72
Course of Pregnancy in Cushing Disease under Different Management Approaches (No Treatment, Surgery, Gamma-Knife or Ketoconazole) 71
P-57 Increased prevalence of acromegaly in an industrialized area of north-east of Sicily: a case-control study 70
Multidisciplinary management of pituitary apoplexy 69
Increased prevalence of acromegaly in a highly polluted area. 68
Peptide receptor radionuclide therapy with 111IN-DTPA-Octreotide in a woman with Cabergoline-resistant giant prolactinoma 68
Resistance to somatostatin analogues is associated with GSTP1 gene methylation and AHR rs2066853 variant in acromegaly patients 66
Epidemiologia degli adenomi ipofisari nel nord-est della Sicilia 64
Thyroid nodules in growth hormone replaced patients. 63
Effectiveness and safety of long-term pegvisomant administration in patients with acromegaly not controlled by other therapies: experience of an Italian center. 62
Cardiovascular events in acromegaly: distinct role of Agatston and Framingham score in the 5-year prediction. 62
Temozolomide-induced shrinkage of a pituitary carcinoma causing Cushing's disease--report of a case and literature review. 61
Increased serum interleukin-22 levels in patients with PRL-secreting and non-functioning pituitary macroadenomas. 61
Effects of pasireotide treatment on cardio-metabolic risk in patients with Cushing's disease: an Italian, multicenter study 60
First report on persistent remission of acromegaly after withdrawal of long-term pegvisomant monotherapy 60
Acromegaly, genetic variants of the aryl hydrocarbon receptor pathway and environmental burden 60
Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience 59
Increased prevalence of restless legs syndrome in patients with acromegaly and effects on quality of life assessed by Acro-QoL. 58
Increased frequency of the rs2066853 variant of aryl hydrocarbon receptor gene in patients with acromegaly 56
First demonstration of the effectiveness of peptide receptor radionuclide therapy (PRRT) with 111In-DTPA-octreotide in a giant PRL-secreting pituitary adenoma resistant to conventional treatment. 55
Biochemical control and clinical improvement is induced by long-term pasireotide administration in the majority of patients with Cushing[apos]s disease persistent after pituitary surgery 55
Pitfalls in the 2017 TNM Classification of Thyroid Carcinoma 53
An extremely rare association of TSH-secreting pituitary adenoma, metastatic neuroendocrine tumor and Cushing’s syndrome in a patient with MEN-1 gene mutation 53
High bone marrow fat in patients with Cushing’s syndrome and vertebral fractures 53
Visceral adiposity index as an indicator of cardiometabolic risk in patients treated for craniopharyngioma 52
Health-related quality of life in patients with Cushing's syndrome 52
Analysis of GPR101 and AIP genes mutations in acromegaly: a multicentric study 50
Effects of cyberknife radiotherapy treatment of pituitary adenomas 50
Comment to ‘glucocorticoid resistance syndrome caused by a novel nr3c1 point mutation’ by al argan et al. 50
Global epidemiology of acromegaly: A systematic review and meta-analysis 50
Temozolomide-induced shrinkage of a pituitary carcinoma. 49
Pasireotide treatment reduces cardiometabolic risk in Cushing's disease patients: an Italian, multicenter study 49
Course of pregnancies in women with Cushing's disease treated by gamma-knife 47
Increased serum brain natriuretic peptide levels are a major predictor of myocardial hypertrophy in acromegalic patients. 47
From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell? 47
Adrenal cancer in neurofibromatosis type 1: case report and DNA analysis 46
An unusual case of idiopathic hyperprolactinemia 46
The ubiquitin-specific peptidase 8 (USP8) gene is frequently mutated in adenomas causing Cushing's disease 45
Absence of GNAS1 mutations in somatotropinomas from AIPmut positive patients: possible implications for phenotype. 45
Increased interleukin 22 circulating levels in patients with tumors involving the hypothalamic-pituitary region 45
Peptide receptor radionuclide therapy (PRRT) in patients with giant aggressive pituitary tumors: experience of an Italian referral center and review of literature 45
Adrenocorticotropin responsiveness to acute octreotide administration is not affected by mifepristone premedication in patients with Cushing's disease. 43
Establishment of a protocol to extend the lifespan of human hormone-secreting pituitary adenoma cells 43
Cardiometabolic Risk in Acromegaly: A Review With a Focus on Pasireotide 42
Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective 42
Global Cushing's disease epidemiology: a systematic review and meta-analysis of observational studies 42
Pregnancy after azathioprine therapy for ulcerative colitis in a woman with autoimmune premature ovarian failure and Addison's disease: HLA haplotype characterization. 40
X-linked acrogigantism: a new condition of growth hormone excess. 40
Landscape of familial isolated and young-onset pituitary adenomas: Prospective diagnosis in AIP mutation carriers 38
Immunohistochemical localization and functional characterization of somatostatin receptor subtypes in a corticotropin releasing hormone-secreting adrenal phaeochromocytoma: review of the literature and report of a case 37
Endocrinologia & Malattie del Metabolismo 37
Neoadjuvant Therapy for Neuroendocrine Neoplasms: Recent Progresses and Future Approaches 37
Cabergoline-related impulse control disorder in an adolescent with a giant prolactinoma 36
A New Clinical Model to Estimate the Pre-Test Probability of Cushing’s Syndrome: The Cushing Score 36
Sequence analysis of the catalytic subunit of PKA in somatotroph adenomas 35
Systemic comorbidities induce early vascular alterations in patients with active acromegaly. 34
Sindromi ipercalcemiche 34
Paradoxical GH increase during OGTT is associated to first-generation somatostatin analogs responsiveness in acromegaly 34
What factors have impact on glucocorticoid replacement in adrenal insufficiency: a real-life study 34
Clinical Consequences of Variable Results in the Measurement of Free Thyroid Hormones: Unusual Presentation of a Family with a Novel Variant in the THRB Gene Causing Resistance to Thyroid Hormone Syndrome 33
Oral mucositis induced by treatment with soft gel formulation of levothyroxine 32
L'acromegalia 32
How to diagnose and manage Cushing's disease during pregnancy, when hypercortisolism is mild? 31
The man with acromegaly who inspired the Shrek animated project. 31
Role of pituitary dysfunction on cardiovascular risk in primary empty sella patients 30
An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis 30
Metabolic comorbidities in Cushing's syndrome 30
Tertiary hypercortisolism due to occult Cushing's syndrome 28
Long-term cardiometabolic outcome in patients with pituitary adenoma diagnosed in chilhood and adolescence 28
Unique clinical picture in patients with X-linked acrogigantism 27
null 27
MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior 27
Somatic Deletion in Exon 10 of Aryl Hydrocarbon Receptor Gene in Human GH-Secreting Pituitary Tumors 27
Methylome Analysis in Nonfunctioning and GH-Secreting Pituitary Adenomas 26
The Enhanced Proteasomal Degradation of AIP Mutant Proteins Is a Mechanism for AIP Deficiency in AIP mutation-Associated Pituitary Adenomas 26
Emerging multitarget tyrosine kinase inhibitors in the treatment of neuroendocrine neoplasms 26
Metabolic syndrome in cushing's syndrome patients 26
GPR101 variants in acromegaly: results from a large series of patients. 25
Effects Of Epigenetic Changes In Gstp1 And Mgmt Gene On Clinicopathological Fatures Of Acromegaly Patients 25
Pituitary Adenomas Harboring AIP Mutations Exhibit Phenotype-Genotype Correlation, but No Association with the Germline FGFR4 G388R Variant or Somatic GNAS1 Mutations 25
Shrinkage of a pituitary metastasis of melanoma induced by pembrolizumab: a case report 25
Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study 23
Gastroenteropancreatic neuroendocrine neoplasms and inflammation: A complex cross-talk with relevant clinical implications 23
Somatic USP8 mutations are frequent events in corticotroph tumor progression causing Nelson's tumor 22
The gene of the ubiquitin-specific protease 8 is frequently mutated in adenomas causing cushing's disease 22
What we have to know about corticosteroids use during Sars-Cov-2 infection 22
Somatic mutations in USP8 are frequent events in pituitary tumors causing Nelson's syndrome 21
Epidemiology, course, and outcomes of Sars-CoV-2 infection in patients with acromegaly and Cushing’s disease: a monocentric experience in Southern Italy 20
A New Clinical Model to Estimate the Pre-Test Probability of Cushing’s Syndrome: The Cushing Score 19
Polymorphism or mutation? - The role of the R304Q missense AIP mutation in the predisposition to pituitary adenoma 18
What we have to know about corticosteroids use during Sars-Cov-2 infection 18
Mitotane concentrations influence outcome in patients with advanced adrenocortical carcinoma 14
Persistent severe visual field impairment is associated with obesity and tumour invasiveness, but not with pituitary dysfunction, in patients with craniopharyngioma 12
Totale 4.438
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.651
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.651
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020399 0 3 3 7 6 86 33 29 19 142 60 11
2020/2021622 24 22 190 31 88 86 34 35 44 34 11 23
2021/2022673 1 69 12 32 18 10 29 23 10 97 120 252
2022/20231.769 167 183 80 140 115 160 37 93 708 15 43 28
2023/2024458 32 76 22 42 39 103 6 47 2 30 4 55
2024/202586 57 29 0 0 0 0 0 0 0 0 0 0
Totale 4.495